321 related articles for article (PubMed ID: 30928169)
61. Follicular lymphoma: time for a re-think?
Gandhi MK; Marcus RE
Blood Rev; 2005 May; 19(3):165-78. PubMed ID: 15748964
[TBL] [Abstract][Full Text] [Related]
62. Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?
Janikova A; Bolcak K; Pavlik T; Mayer J; Kral Z
Clin Lymphoma Myeloma; 2008 Oct; 8(5):287-93. PubMed ID: 18854283
[TBL] [Abstract][Full Text] [Related]
63. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
[TBL] [Abstract][Full Text] [Related]
64. Emerging issues after the recognition of in situ follicular lymphoma.
Carbone A; Gloghini A
Leuk Lymphoma; 2014 Mar; 55(3):482-90. PubMed ID: 23713483
[TBL] [Abstract][Full Text] [Related]
65. [Management strategy for follicular lymphoma].
Fukuhara N
Rinsho Ketsueki; 2017; 58(10):2020-2025. PubMed ID: 28978844
[TBL] [Abstract][Full Text] [Related]
66. Follicular lymphoma: an update on diagnosis, prognosis, and management.
Mozas P; Sorigué M; López-Guillermo A
Med Clin (Barc); 2021 Nov; 157(9):440-448. PubMed ID: 34210513
[TBL] [Abstract][Full Text] [Related]
67. Novel acquisitions on biology and management of transformed follicular lymphoma.
Minoia C; Zucca E; Conconi A
Hematol Oncol; 2018 Oct; 36(4):617-623. PubMed ID: 29602222
[TBL] [Abstract][Full Text] [Related]
68. The investigation and management of follicular lymphoma.
McNamara C; Montoto S; Eyre TA; Ardeshna K; Burton C; Illidge T; Linton K; Rule S; Townsend W; Wong WL; McKay P
Br J Haematol; 2020 Nov; 191(3):363-381. PubMed ID: 32579717
[No Abstract] [Full Text] [Related]
69. [Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia].
Nesterova ES; Kravchenko SK; Mangasarova YK; Baryakh EA; Misyurina AE; Vorobyev VI; Plastinina LV; Chernova NG; Kovrigina AM; Obukhova TN; Klyasova GA; Shevelev AA; Kostina IE; Gemdzhian EG; Gaponova TV; Vorobyev AI
Ter Arkh; 2016; 88(7):62-71. PubMed ID: 27459617
[TBL] [Abstract][Full Text] [Related]
70. Efficacy of idelalisib as bridge to allogeneic stem cell transplant in relapsed follicular lymphoma: a case report.
Marangon M; Pellegrini C; Argnani L; Zinzani PL
Tumori; 2017 Nov; 103(Suppl. 1):e41-e43. PubMed ID: 28967090
[TBL] [Abstract][Full Text] [Related]
71. Aggressive treatment in follicular non-Hodgkin's lymphoma.
Schouten HC
Br J Hosp Med; 1996 Nov 20-Dec 10; 56(10):525-8. PubMed ID: 8958406
[No Abstract] [Full Text] [Related]
72. Prognostic factors in follicular lymphoma.
Relander T; Johnson NA; Farinha P; Connors JM; Sehn LH; Gascoyne RD
J Clin Oncol; 2010 Jun; 28(17):2902-13. PubMed ID: 20385990
[TBL] [Abstract][Full Text] [Related]
73. [Follicular lymphoma].
Tomita N
Nihon Rinsho; 2014 Mar; 72(3):488-92. PubMed ID: 24724409
[TBL] [Abstract][Full Text] [Related]
74. Refining the treatment of follicular lymphoma.
Buske C; Gisselbrecht C; Gribben J; Letai T; McLaughlin P; Wilson W
Leuk Lymphoma; 2008; 49 Suppl 1():18-26. PubMed ID: 18821429
[TBL] [Abstract][Full Text] [Related]
75. Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation.
van den Brand M; van der Velden WJ; Diets IJ; Ector GI; de Haan AF; Stevens WB; Hebeda KM; Groenen PJ; van Krieken HJ
Leuk Lymphoma; 2016 Jul; 57(7):1649-56. PubMed ID: 26694256
[TBL] [Abstract][Full Text] [Related]
76. Copanlisib: An Intravenous Phosphatidylinositol 3-Kinase (PI3K) Inhibitor for the Treatment of Relapsed Follicular Lymphoma.
Eltantawy A; Vallejos X; Sebea E; Evans K
Ann Pharmacother; 2019 Sep; 53(9):954-958. PubMed ID: 30813760
[No Abstract] [Full Text] [Related]
77. The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
Keeney GE; Gooley TA; Pham RN; Press OW; Pagel JM; Petersdorf SH; Maloney DG; Bensinger W; Holmberg L; Gopal AK
Leuk Lymphoma; 2007 Oct; 48(10):1961-7. PubMed ID: 17917964
[TBL] [Abstract][Full Text] [Related]
78. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
[TBL] [Abstract][Full Text] [Related]
79. Autologous transplant of follicular lymphoma in the era of rituximab.
Witzens-Harig M; Dreger P
Leuk Lymphoma; 2010 Jun; 51(6):967-74. PubMed ID: 20443675
[TBL] [Abstract][Full Text] [Related]
80. Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.
Fernández de Larrea C; Martínez-Pozo A; Mercadal S; García A; Gutierrez-García G; Valera A; Ghita G; Colomo L; Gainza E; Villamor N; Nomdedeu B; Estrach T; Montserrat E; Campo E; López-Guillermo A
Br J Haematol; 2011 May; 153(3):334-40. PubMed ID: 21375524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
